LBRDK Liberty beats Q3 2025 EPS estimates by nearly 40 percent yet shares fall 806 percent in todays session AmericanDrug DMAAR Stock This Week 428 20260427 DLO DLocal posts narrow Q4 2025 EPS beat shares gain 338 percent after earnings release Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval UXIN Uxin shares gain 319 percent following release of its 2025 first quarter earnings update Salesforce Inc CRM Bearish Risks Mount Amid AI Pricing Pushback Competitive Pressures and Federal Contract Uncertainty